Pierre Péterlin

4.0k citations
111 papers · 1.1k · h-index 19

Impact in

  • Hematology top 1%
    • Hematopoietic Stem Cell Transplantation
    • Acute Myeloid Leukemia Research
  • Immunology top 10%
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology

Papers in

  • Hematology 71
    • Hematopoietic Stem Cell Transplantation 38
    • Acute Myeloid Leukemia Research 36
    • Chronic Myeloid Leukemia Treatments 11
    • Multiple Myeloma Research and Treatments 10
  • Oncology 37
    • CAR-T cell therapy research 10
Co-authors
Patrice Chevallier (80 shared papers)Thierry Guillaume (70 shared papers)Alice Garnier (63 shared papers)Philippe Moreau (45 shared papers)Amandine Le Bourgeois (49 shared papers)Marie C. Béné (44 shared papers)Mohamad Mohty (22 shared papers)Thomas Gastinne (29 shared papers)
Journals
Blood (33 papers)Bone Marrow Transplantation (8 papers)Annals of Hematology (7 papers)Biology of Blood and Marrow Transplantation (5 papers)Haematologica (3 papers)
Partner nations
FranceUnited StatesCanada

In The Last Decade

Pierre Péterlin

102 papers receiving 1.1k citations

Peers

Pierre Péterlin
Comparison fields: 5 of 68
  • Hematology 640
  • Immunology 284
  • Oncology 296
  • Genetics 103
  • Infectious Diseases 147
Replace Rémy Duléry with:
Rémy Duléry France
Usama Gergis United States
Xavier Poiré Belgium
Alice Garnier France
Pascual Balsalobre Spain
Édouard Forcade France
Kavita Raj United Kingdom
Roni Tamari United States
Anna Ghiso Italy
A Iriondo Spain
Pierre Péterlin relative to Rémy Duléry France Rémy Duléry's profile →
Citations per field
00.5×1.5×1.8×
Rémy Duléry · 1×
Citations per year

Countries citing papers authored by Pierre Péterlin

Since Specialization
Citations

This map shows the geographic impact of Pierre Péterlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Péterlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Péterlin more than expected).

Fields of papers citing papers by Pierre Péterlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Péterlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Péterlin. The network helps show where Pierre Péterlin may publish in the future.

Co-authors

The 25 scholars most cited alongside Pierre Péterlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pierre Péterlin Line = papers co-authored together Pierre Péterlin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 111 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome
Bone Marrow Transplantation ·Thierry Guillaume, Florent Malard, Léonardo Magro, Myriam Labopin, Reza Tabrizi, Cécile Borel, Patrice Chevallier, Stéphane Vigouroux, Pierre Péterlin, Alice Garnier, Marie‐Thérèse Rubio, Anne Huynh, Nöel Milpied, Philippe Moreau, Béatrice Gaugler, Ibrahim Yakoub‐Agha, Mohamad Mohty
201964
2
Impact on early outcomes and immune reconstitution of high-dose post-transplant cyclophosphamide vs anti-thymocyte globulin after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation
Oncotarget ·Christelle Retière, Catherine Willem, Thierry Guillaume, Henri Vié, Laetitia Gautreau‐Rolland, Emmanuel Scotet, Xavier Saulquin, Katia Gagne, Marie C. Béné, Berthe‐Marie Imbert, Béatrice Clemenceau, Pierre Péterlin, Alice Garnier, Patrice Chevallier
201848
3
Azacitidine salvage therapy for relapse of myeloid malignancies following allogeneic hematopoietic SCT
Bone Marrow Transplantation ·Benoît Tessoulin, J. Delaunay, Patrice Chevallier, Marion Loirat, Sameh Ayari, Pierre Péterlin, Steven Le Gouill, Thomas Gastinne, Philippe Moreau, Mohamad Mohty, Thierry Guillaume
201446
4
Nationwide survey on the use of eltrombopag in patients with severe aplastic anemia: a report on behalf of the French Reference Center for Aplastic Anemia
Haematologica ·Étienne Lengliné, Bernard Drénou, Pierre Péterlin, Olivier Tournilhac, Julie Abraham, Ana Berceanu, Brigitte Dupriez, Gaëlle Guillerm, Emmanuel Raffoux, Flore Sicre de Fontbrune, Lionel Adès, Marie Balsat, Driss Chaoui, Paul Coppo, Sélim Corm, Thierry Leblanc, Natacha Maillard, Louis Terriou, Gèrard Socié, Régis Peffault de Latour
201746
5
Larger number of invariant natural killer T cells in PBSC allografts correlates with improved GVHD-free and progression-free survival
Blood ·Florent Malard, Myriam Labopin, Patrice Chevallier, Thierry Guillaume, Alix Duquesne, Fanny Rialland, Sophie Derenne, Pierre Péterlin, A.G. Chartois Leaute, Éolia Brissot, Marc Grégoire, Philippe Moreau, Philippe Saas, Béatrice Gaugler, Mohamad Mohty
201643
6
A Phase 1b Study Evaluating the Safety and Efficacy of Venetoclax in Combination with Azacitidine in Treatment-Naïve Patients with Higher-Risk Myelodysplastic Syndrome
Blood ·Andrew H. Wei, Jacqueline S. Garcia, Uma Borate, Chun Yew Fong, Maria R. Baer, Florian Nolte, Pierre Péterlin, Joseph G. Jurcic, Guillermo Garcia‐Manero, Wan‐Jen Hong, Uwe Platzbecker, Olatoyosi Odenike, Martin Dunbar, Ying Zhou, Jason G. Harb, Poonam Tanwani, Johannes Wolff, Meagan A. Jacoby
201940
7
Safety and Antibody Response After 1 and 2 Doses of BNT162b2 mRNA Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant
JAMA Network Open ·Amandine Le Bourgeois, Marianne Coste‐Burel, Thierry Guillaume, Pierre Péterlin, Alice Garnier, Marie C. Béné, Patrice Chevallier
202139
8
Sequential regimen of clofarabine, cytosine arabinoside and reduced-intensity conditioned transplantation for primary refractory acute myeloid leukemia
Haematologica ·Mohamad Mohty, Florent Malard, Didier Blaise, Nöel Milpied, Gèrard Socié, Anne Huynh, Oumédaly Reman, Ibrahim Yakoub‐Agha, Sabine Fürst, Thierry Guillaume, R. Tabrizi, Stéphane Vigouroux, Pierre Péterlin, Jean El Cheikh, Philippe Moreau, Myriam Labopin, Patrice Chevallier
201636
9
Deconditioning, fatigue and impaired quality of life in long-term survivors after allogeneic hematopoietic stem cell transplantation
Bone Marrow Transplantation ·S. Dirou, Arnaud Chambellan, Patrice Chevallier, P. Germaud, Guillaume Lamirault, Pierre‐Antoine Gourraud, Bastien Perrot, Béatrice Delasalle, Bastien Forestier, Thierry Guillaume, Pierre Péterlin, Alice Garnier, A. Magnan, F.–X. Blanc, Patricia Lemarchand
201733
10
Impact of KIR/HLA Incompatibilities on NK Cell Reconstitution and Clinical Outcome after T Cell–Replete Haploidentical Hematopoietic Stem Cell Transplantation with Posttransplant Cyclophosphamide
The Journal of Immunology ·Catherine Willem, Dhon Roméo Makanga, Thierry Guillaume, Bercelin Maniangou, Nolwenn Legrand, Katia Gagne, Pierre Péterlin, Alice Garnier, Marie C. Béné, Anne Cesbron, Amandine Le Bourgeois, Patrice Chevallier, Christelle Retière
201932
11
Progression of disease within 2 years (POD24) is a clinically relevant endpoint to identify high-risk follicular lymphoma patients in real life
Annals of Hematology ·Clara Sortais, Anne Lok, Benoît Tessoulin, Thomas Gastinne, Beatrice Mahé, Viviane Dubruille, Nicolas Blin, Cyrille Touzeau, (unknown), Céline Bossard, Pierre Péterlin, Alice Garnier, Thierry Guillaume, Amandine Le Bourgeois, Patrice Chevallier, Philippe Moreau, Christophe Leux, Steven Le Gouill
202031
12
Upfront allogeneic stem-cell transplantation for patients with nonlocalized untreated peripheral T-cell lymphoma: an intention-to-treat analysis from a single center
Annals of Oncology ·Marion Loirat, Patrice Chevallier, Christophe Leux, Philippe Moreau, Céline Bossard, Thierry Guillaume, Thomas Gastinne, J. Delaunay, Nicolas Blin, Beatrice Mahé, Viviane Dubruille, Karine Augeul-Meunier, Pierre Péterlin, Hervé Maisonneuve, Nadine Juge‐Morineau, Henry Jardel, Mohamad Mohty, Steven Le Gouill
201430
13
Prevalence of the reversed halo sign in neutropenic patients compared with non‐neutropenic patients: Data from a single‐centre study involving 27 patients with pulmonary mucormycosis (2003‐2016)
Mycoses ·Jessie Bourcier, Pierre‐Marie Heudes, Florent Morio, Thomas Gastinne, Patrice Chevallier, Fanny Rialland, Claire F. Garandeau, Isabelle Danner‐Boucher, Patrice Le Pape, Éric Frampas, Philippe Moreau, C. Defrance, Pierre Péterlin
201728
14
Safety and immunogenicity of a first dose of SARS‐CoV‐2 mRNA vaccine in allogeneic hematopoietic stem‐cells recipients
eJHaem ·Patrice Chevallier, Marianne Coste‐Burel, Amandine Le Bourgeois, Pierre Péterlin, Alice Garnier, Marie C. Béné, Berthe‐Marie Imbert, Thomas Drumel, Steven Le Gouill, Philippe Moreau, Beatrice Mahé, Viviane Dubruille, Nicolas Blin, Anne Lok, Cyrille Touzeau, Thomas Gastinne, Maxime Jullien, Sophie Vanthygem, Thierry Guillaume
202126
15
Prophylactic or Preemptive Low-Dose Azacitidine and Donor Lymphocyte Infusion to Prevent Disease Relapse following Allogeneic Transplantation in Patients with High-Risk Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Transplantation and Cellular Therapy ·Thierry Guillaume, Sylvain Thépot, Pierre Péterlin, Patrice Céballos, Amandine Le Bourgeois, Alice Garnier, Corentin Orvain, Aurélien Giltat, Sylvie François, Yannick Le Bris, Clémentine Fronteau, Lucie Planche, Patrice Chevallier
202124
16
Single-agent daratumumab in very advanced relapsed and refractory multiple myeloma patients: a real-life single-center retrospective study
Annals of Hematology ·Maxime Jullien, Sabrina Trudel, Benoît Tessoulin, Beatrice Mahé, Viviane Dubruille, Nicolas Blin, Thomas Gastinne, Antoine Bonnet, Anne Lok, Amandine Lebourgeois, Pierre Péterlin, Alice Garnier, Patrice Chevalier, Thierry Guillaume, P. Thomaré, Steven Le Gouill, Philippe Moreau, Cyrille Touzeau
201923
17
SARS-CoV-2 T-Cell Responses in Allogeneic Hematopoietic Stem Cell Recipients following Two Doses of BNT162b2 mRNA Vaccine
Vaccines ·Béatrice Clemenceau, Thierry Guillaume, Marianne Coste‐Burel, Pierre Péterlin, Alice Garnier, Amandine Le Bourgeois, Maxime Jullien, Jocelyn Ollier, Audrey Grain, Marie C. Béné, Henri Vié, Patrice Chevallier
202220
18
A phase I/II feasibility vaccine study by autologous leukemic apoptotic corpse-pulsed dendritic cells for elderly AML patients
Human Vaccines & Immunotherapeutics ·Patrice Chevallier, Soraya Saïagh, Virginie Dehame, Thierry Guillaume, Pierre Péterlin, Sylvain Bercegeay, Yannick Le Bris, Céline Bossard, Isabelle Gauvrit, Brigitte Dréno, Nadine Juge‐Morineau, Marie C. Béné, Marc Grégoire
202120
19
In-depth time-dependent analysis of the benefit of allo-HSCT for elderly patients with CR1 AML: a FILO study
Blood Advances ·Raynier Devillier, Édouard Forcade, Alice Garnier, Sarah Guenounou, Sylvain Thépot, Gaëlle Guillerm, Patrice Céballos, Yosr Hicheri, Pierre‐Yves Dumas, Pierre Péterlin, Mathilde Hunault, Marie C. Béné, Anne Bouvier, Patrice Chevallier, Didier Blaise, Norbert Vey, Arnaud Pigneux, Christian Récher, Anne Huynh
202118
20
Genetic and Molecular Basis of Heterogeneous NK Cell Responses against Acute Leukemia
Cancers ·Dhon Roméo Makanga, Francesca Da Rin de Lorenzo, Gaëlle David, Catherine Willem, Léa Dubreuil, Nolwenn Legrand, Thierry Guillaume, Pierre Péterlin, Amandine Lebourgeois, Marie C. Béné, Alice Garnier, Patrice Chevallier, Ketevan Gendzekhadze, Anne Cesbron, Katia Gagne, Béatrice Clemenceau, Christelle Retière
202017

About Pierre Péterlin

Pierre Péterlin is a scholar working on Hematology, Oncology, Immunology, Molecular Biology and Infectious Diseases, having authored 111 papers that have together received 1.1k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (38 papers), Acute Myeloid Leukemia Research (36 papers), Immune Cell Function and Interaction (16 papers), Chronic Myeloid Leukemia Treatments (11 papers), Multiple Myeloma Research and Treatments (10 papers), CAR-T cell therapy research (10 papers), Acute Lymphoblastic Leukemia research (9 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). The work is most often cited by research in Hematology (640 citations), Immunology (284 citations), Oncology (296 citations), Genetics (103 citations) and Infectious Diseases (147 citations). Pierre Péterlin has collaborated with scholars based in France, United States and Canada. Frequent co-authors include Patrice Chevallier, Thierry Guillaume, Alice Garnier, Philippe Moreau, Amandine Le Bourgeois, Marie C. Béné, Mohamad Mohty, Thomas Gastinne, Steven Le Gouill and Nicolas Blin. Their work appears in journals such as Blood, Bone Marrow Transplantation, Annals of Hematology, Biology of Blood and Marrow Transplantation and Haematologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rémy DuléryBreakdown of academic impact, for papers by Usama GergisBreakdown of academic impact, for papers by Xavier PoiréBreakdown of academic impact, for papers by Alice GarnierBreakdown of academic impact, for papers by Pascual BalsalobreBreakdown of academic impact, for papers by Édouard ForcadeBreakdown of academic impact, for papers by Kavita RajBreakdown of academic impact, for papers by Roni TamariBreakdown of academic impact, for papers by Anna GhisoBreakdown of academic impact, for papers by A Iriondo